---
title: "Maternal Respiratory Syncytial Virus Vaccination and Receipt of Respiratory Syncytial Virus Antibody (Nirsevimab) by Infants Aged 8 Months - United States, April 2024"
source_url: "https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=752791"
source_layer: us_cdc_mmwr
category: surveillance_summary
date: 2024-09-26
confidence: 中
mmwr_volume: ""
mmwr_issue: ""
---

## 摘要

This report describes the percentage of infants protected against respiratory syncytial virus from maternal RSV vaccination, nirsevimab, or both.

## 詳細內容

This report describes the percentage of infants protected against respiratory syncytial virus from maternal RSV vaccination, nirsevimab, or both.

## 關鍵發現

(需要透過 WebFetch 補充或人工審核來提取關鍵發現)

---
*萃取時間: 2026-02-05T15:09:37Z*
*資料來源: CDC MMWR*
